ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

デロラゼパム

Delorazepam

HCID 17925
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
2894-67-9
標準SMILES
O=C1CN=C(c2ccccc2Cl)c2cc(Cl)ccc2N1
InChIKey
CHIFCDOIPRCHCF-UHFFFAOYSA-N
分子式
C15H10Cl2N2O
平均分子量
305.2 g/mol
単同位体質量
304.0170183

概要

Delorazepam is a benzodiazepine.

名称と識別子

優先名称
Delorazepam
IUPAC
7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
現地名
デロラゼパム
英語名
Delorazepam
分子式
C15H10Cl2N2O
分子量
305.16

名称と別名

Delorazepam2894-67-9ChlordemethyldiazepamB1, BenzodiazepineCl-DMDZ2-Chloronordiazepam2'-chloronordiazepamDadumirRo 5-3027RV-121652H-1,4-Benzodiazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
名称をさらに表示
1,3-ジヒドロ-7-クロロ-5-(2-クロロフェニル)-2H-1,4-ベンゾジアゼピン-2-オンo-クロロデスメチルジアゼパム2'-クロロノルジアゼパム5-(o-クロロフェニル)-7-クロロ-1,3-ジヒドロ-2H-1,4-ベンゾジアゼピン-2-オン5-(2-クロロフェニル)-7-クロロ-1H-1,4-ベンゾジアゼピン-2(3H)-オン7-クロロ-5-(2-クロロフェニル)-1,3-ジヒドロ-2H-1,4-ベンゾジアゼピン-2-オン5-[2-クロロフェニル]-7-クロロ-1H-1,4-ベンゾジアゼピン-2(3H)-オンクロルデスメチルジアゼパムデロラゼパム7-クロロ-5-(o-クロロフェニル)-1,3-ジヒドロ-2H-1,4-ベンゾジアゼピン-2-オン7-クロロ-5-(2-クロロフェニル)-1H-1,4-ベンゾジアゼピン-2(3H)-オン7-クロロ-1,3-ジヒドロ-5-(2-クロロフェニル)-2H-1,4-ベンゾジアゼピン-2-オンクロロデスメチルジアゼパムクロルデメチルジアゼパム7-クロロ-5-(2-クロロフェニル)-2,3-ジヒドロ-1H-1,4-ベンゾジアゼピン-2-オン2′-クロロノルジアゼパムEN7-Chloro-1,3-dihydro-5-(2-chlorophenyl)-2H-1,4-benzodiazepin-2-one7-Chloro-5-(2-Chlorophenyl)-1,3-Dihydro-3H-1,4-Dibenzodiazopine-2-OneE5NTL-VAPCALJAL-VAP-2
NSC-169895DTXSID70183137O91W32476G1,3-Dihydro-7-chloro-5-(o-chlorophenyl)-2H-1,4-benzodiazepin-2-onechlorodesmethyldiazepamNSC169895RefChem:5856737-chloro-5-(2-chlorophenyl) 1,3-dihydro-2H-1,4-benzodiazepin-2-one

データベース識別子

CAS
2894-67-9
PubChem CID
17925
DTXSID
DTXSID70183137
ChEMBL
CHEMBL268254
ChEBI
CHEBI:135295
UNII
O91W32476G
EC Number
220-771-9
Nikkaji
J7.928F

物性

構造計算による物性

XLogP
3.1
極性表面積
41.5 Ų
水素結合供与体数
1
水素結合受容体数
2
回転可能結合数
1
重原子数
20
形式電荷
0
複雑度
413

実験および物理化学的性質

Drugs · 4 件

DEA NFLIS-Drug Category -> Benzodiazepines

DEA Schedule IV Controlled Substance -> Depressants

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals -> Synthetic Cannabinoids or Psychoactive Compounds

LogP3.15
Human DrugsPharmaceuticals

物理化学的性質

融点
187 · 187-189°C
沸点
481.7 · 481.7±45.0 °C(Predicted)
比重(密度)
1.42 · 1.42±0.1 g/cm3(Predicted)
闪点
Not applicable
貯蔵温度
2 · 2-8°C
溶解性
30 mg/ml; · DMF: 30 mg/ml; DMSO: 30 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 10 mg/ml
酸解離定数(Pka)
11.58 · 11.58±0.70(Predicted)
外見
buffered aqueous solution
由来生物
mouse
InChIKey
CHIFCDOIPRCHCF-UHFFFAOYSA-N
CAS データベース
2894 · 2894-67-9(CAS DataBase Reference)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (97.6%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 2 notifications to the ECHA C&L Inventory.

危険有害性情報

Regulatory Information · 2 件

DEA schedule IV controlled substance

REACH registered substance: Delorazepam (EC: 220-771-9)

Hazard Classes and CategoriesAcute Tox. 4 (97.6%)

毒性情報

Treatment · 1 件

General supportive measures should be employed, along with intravenous fluids, and an adequate airway maintained. Hypotension may be combated by the use of norepinephrine or metaraminol. Dialysis is of limited value. Flumazenil (Anexate) is a competitive benzodiazepine receptor antagonist that can be used as an antidote for benzodiazepine overdose. In particular, flumazenil is very effective at reversing the CNS depression associated with benzodiazepines but is less effective at reversing respiratory depression. Its use, however, is controversial as it has numerous contraindications. It is contraindicated in patients who are on long-term benzodiazepines, those who have ingested a substance that lowers the seizure threshold, or in patients who have tachycardia or a history of seizures. As a general rule, medical observation and supportive care are the mainstay of treatment of benzodiazepine overdose. Although benzodiazepines are absorbed by activated charcoal, gastric decontamination with activated charcoal is not beneficial in pure benzodiazepine overdose as the risk of adverse effects often outweigh any potential benefit from the procedure. It is recommended only if benzodiazepines have been taken in combination with other drugs that may benefit from decontamination. Gastric lavage (stomach pumping) or whole bowel irrigation are also not recommended.

化学と産業

薬理情報

Protein Binding>90% protein bound.
Biological Half-LifeVery long elimination half life of 80-115 hours, varying with age. Elimination is slower as age increases. [1] Liver disease also impacts elimination half life, with impairment resulting in half lives up to 395 hours.
Metabolism/Metabolites · 2 件

Delorazepam is metabolized at a relatively slow pace by the liver. The major metabolite (15-34% of the parent drug) is lorazepam. Older patients metabolize delorazepam slower than younger patients.

Delorazepam is metabolized at a relatively slow pace by the liver. The major metabolite (15-34% of the parent drug) is lorazepam. Older patients metabolize delorazepam slower than younger patients.

MeSH Pharmacological ClassificationDrugs used to prevent SEIZURES or reduce their severity.
Absorption, Distribution and Excretion · 4 件

77-87% oral bioavailability, with a relatively slow absorption rate. Reaches peak plasma levels within 1-2 hours of administration. Food may slow absorption, however other pharmacokinetic variables remain unchanged. After multiple doses delorazepam accumulates, although accumulation is slower in younger patients.

Renally eliminated.

140 L/kg apparent volume of distribution in 11 patients with normal renal function; 47 L/kg in 11 patients with renal failure and on regular hemodialysis. In another study, apparent volume of distribution was 65 L/kg in 8 patients with liver disease and 118.4 L/kg in 12 healthy controls.

Still detectable 72 hours after dosing in healthy patients. Patients with liver disease experienced a reduction in clearance from 0.13 to 0.25 ng/mLh.

用途と製造

Uses · 1 件

Mainly used as an anti-anxiety agent. Studies have found delorazepam to be more effective in the first 4 weeks of use than antidepressants; however, after 4 weeks, antidepressants showed superior anti-anxiety effects. Anti-anxiety effects also appear to be weaker in elderly patients. Effectiveness has also been observed in the treatment of alcohol withdrawal. Delorazapam was reported to be a manageable drug in that it did not exhibit severe side effects and did not require further therapies to control symptoms of withdrawal.

関連反応

9 件
反応記録を作成
HRID 649264 の反応式
HRID 649264反応物として
HRID 649266 の反応式
HRID 649266反応物として
HRID 673356 の反応式
HRID 673356反応物として
HRID 805703 の反応式
HRID 805703反応物として
HRID 1076389 の反応式
HRID 1076389反応物として
HRID 1138462 の反応式
HRID 1138462反応物として
HRID 1148992 の反応式
HRID 1148992反応物として
HRID 1156237 の反応式
HRID 1156237反応物として
前へ1 / 2 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
NISTの化学物質情報
Delorazepam(2894-67-9)

化学的性質

化学的特性Off-White to Light Yellow Solid

Exposure Routes · 1 件

77-87% oral bioavailability, with a relatively slow absorption rate. Reaches peak plasma levels within 1-2 hours of administration. Food may slow absorption, however other pharmacokinetic variables remain unchanged. After multiple doses delorazepam accumulates, however accumulation is slower in younger patients.

Toxicity Summary · 1 件

Benzodiazepines bind nonspecifically to benzodiazepine receptors BNZ1, which mediates sleep, and BNZ2, which affects affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell.

Signs and SymptomsOlder patients metabolize delorazepam slower than younger patients and thus suffer from more adverse effects.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

安全データ

wgk
3
rtecs
DF2367500
ridadr
UN 1230 3/PG 2
毒性
LD50 oral in rat: 2gm/kg
risk_code
22-39/23/24/25-23/24/25-11
hazard_code
Xn,T,F
safety_code
36/37/39-45-36/37-16-7
ストレージクラス
10 - Combustible liquids
Use ClassificationPharmaceuticals

応用分野

使用Controlled Substance